SEC Comment Letter 0000000000-23-000083 to MAINZ BIOMED N.V. (MYNZ) (CIK 0001874252) (MYNZ)
MAINZ BIOMED N.V. (MYNZ) (CIK 0001874252)
Date: Jan. 4, 2023 · CIK: 0001874252 · Accession: 0000000000-23-000083
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-269091
Letter
United States securities and exchange commission logo January 4, 2023 Guido Baechler Chief Executive Officer Mainz Biomed N.V. Robert Koch Strasse 50 55129 Mainz Germany Re:Mainz Biomed N.V. Registration Statement on Form F-3 Filed December 30, 2022 File No. 333-269091 Dear Guido Baechler: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Tim Dockery
Show Raw Text
United States securities and exchange commission logo
January 4, 2023
Guido Baechler
Chief Executive Officer
Mainz Biomed N.V.
Robert Koch Strasse 50
55129 Mainz
Germany
Re:Mainz Biomed N.V.
Registration Statement on Form F-3
Filed December 30, 2022
File No. 333-269091
Dear Guido Baechler:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jason Drory at 202-551-8342 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Tim Dockery